Sulesomab is a mouse monoclonal antibody that targets the granulocyte associated NCA-90 cell antigen. Sulesomab has been used as an in vivo granulocyte labeling agent for imaging inflammation.
BOC Sciences specializes in small molecule synthesis, biosynthesis, purification, and characterization. It provides a wide range of research chemicals and biochemicals, including inhibitors, building blocks, carbohydrates, nucleosides, nucleotides, GMP Products, impurities and metabolites, APIs, natural compounds, ADCs, stem cell molecules and chiral compounds.